Literature DB >> 22886561

Genetics of familial forms of thrombocytopenia.

Carlo L Balduini1, Anna Savoia.   

Abstract

The joint application of clinical and genetic investigation to patients with inherited thrombocytopenias, as well as the availability of new methods for studying megakaryopoiesis, has greatly expanded the knowledge of these disorders in the last few years with regard to their etiology, pathogenesis and clinical aspects. In particular, new diseases have been described, as deriving from mutations in the genes FLNA, TUBB1, ITGA2/ITGB3, ANKRD26, CYCS, and ABCG5 or ABCG8. Moreover, forms previously considered separate entities were found to be different clinical aspects of a single disease. For instance, identification of MYH9 as the gene whose mutations cause the May-Hegglin anomaly led to the recognition that Sebastian platelet syndrome, Epstein syndrome, and Fechtner syndrome derive from mutations of the same gene and describe overlapping disorders. Despite these advances, knowledge of hereditary thrombocytopenias is still far from satisfactory because for approximately half of the patients it is not possible to formulate a definite diagnosis in that their illnesses has not yet been described. In this review, we provide a systematic description of hereditary thrombocytopenias as we know them today, giving special attention to genetic aspects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886561     DOI: 10.1007/s00439-012-1215-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  88 in total

Review 1.  Perspectives on RUNX genes: an update.

Authors:  M Michael Cohen
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

2.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.

Authors:  W J Song; M G Sullivan; R D Legare; S Hutchings; X Tan; D Kufrin; J Ratajczak; I C Resende; C Haworth; R Hock; M Loh; C Felix; D C Roy; L Busque; D Kurnit; C Willman; A M Gewirtz; N A Speck; J H Bushweller; F P Li; K Gardiner; M Poncz; J M Maris; D G Gilliland
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

3.  Gray platelet syndrome. A variety of qualitative platelet disorder.

Authors:  G Raccuglia
Journal:  Am J Med       Date:  1971-12       Impact factor: 4.965

4.  Wiskott Aldrich syndrome: an immunodeficiency syndrome not rare in Western Australia.

Authors:  C Somerville; K D Forsyth
Journal:  Pediatr Allergy Immunol       Date:  1993-05       Impact factor: 6.377

5.  An autosomal dominant thrombocytopenia gene maps to chromosomal region 10p.

Authors:  A Savoia; M Del Vecchio; A Totaro; S Perrotta; G Amendola; A Moretti; L Zelante; A Iolascon
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

6.  The 11q terminal deletion disorder: a prospective study of 110 cases.

Authors:  Paul D Grossfeld; Teresa Mattina; Zona Lai; Remi Favier; Ken Lyons Jones; Finbarr Cotter; Christopher Jones
Journal:  Am J Med Genet A       Date:  2004-08-15       Impact factor: 2.802

7.  Novel heterozygous missense mutation in the second leucine rich repeat of GPIbalpha affects GPIb/IX/V expression and results in macrothrombocytopenia in a patient initially misdiagnosed with idiopathic thrombocytopenic purpura.

Authors:  Shinji Kunishima; Toshi Imai; Motohiro Hamaguchi; Hidehiko Saito
Journal:  Eur J Haematol       Date:  2006-04       Impact factor: 2.997

8.  Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano.

Authors:  A Balduini; A Malara; A Pecci; S Badalucco; V Bozzi; I Pallotta; P Noris; M Torti; C L Balduini
Journal:  J Thromb Haemost       Date:  2008-12-04       Impact factor: 5.824

9.  NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules.

Authors:  Meral Gunay-Aygun; Tzipora C Falik-Zaccai; Thierry Vilboux; Yifat Zivony-Elboum; Fatma Gumruk; Mualla Cetin; Morad Khayat; Cornelius F Boerkoel; Nehama Kfir; Yan Huang; Dawn Maynard; Heidi Dorward; Katherine Berger; Robert Kleta; Yair Anikster; Mutlu Arat; Andrew S Freiberg; Beate E Kehrel; Kerstin Jurk; Pedro Cruz; Jim C Mullikin; James G White; Marjan Huizing; William A Gahl
Journal:  Nat Genet       Date:  2011-07-17       Impact factor: 38.330

10.  Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome.

Authors:  Cornelis A Albers; Dirk S Paul; Harald Schulze; Kathleen Freson; Jonathan C Stephens; Peter A Smethurst; Jennifer D Jolley; Ana Cvejic; Myrto Kostadima; Paul Bertone; Martijn H Breuning; Najet Debili; Panos Deloukas; Rémi Favier; Janine Fiedler; Catherine M Hobbs; Ni Huang; Matthew E Hurles; Graham Kiddle; Ingrid Krapels; Paquita Nurden; Claudia A L Ruivenkamp; Jennifer G Sambrook; Kenneth Smith; Derek L Stemple; Gabriele Strauss; Chantal Thys; Chris van Geet; Ruth Newbury-Ecob; Willem H Ouwehand; Cedric Ghevaert
Journal:  Nat Genet       Date:  2012-02-26       Impact factor: 38.330

View more
  22 in total

1.  ACTN1 mutations cause congenital macrothrombocytopenia.

Authors:  Shinji Kunishima; Yusuke Okuno; Kenichi Yoshida; Yuichi Shiraishi; Masashi Sanada; Hideki Muramatsu; Kenichi Chiba; Hiroko Tanaka; Koji Miyazaki; Michio Sakai; Masatoshi Ohtake; Ryoji Kobayashi; Akihiro Iguchi; Gen Niimi; Makoto Otsu; Yoshiyuki Takahashi; Satoru Miyano; Hidehiko Saito; Seiji Kojima; Seishi Ogawa
Journal:  Am J Hum Genet       Date:  2013-02-21       Impact factor: 11.025

2.  GATA1 Binding Kinetics on Conformation-Specific Binding Sites Elicit Differential Transcriptional Regulation.

Authors:  Atsushi Hasegawa; Hiroshi Kaneko; Daishi Ishihara; Masahiro Nakamura; Akira Watanabe; Masayuki Yamamoto; Cecelia D Trainor; Ritsuko Shimizu
Journal:  Mol Cell Biol       Date:  2016-07-29       Impact factor: 4.272

3.  Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP.

Authors:  Alexandra Schifferli; Andrea Heiri; Paul Imbach; Susanne Holzhauer; Markus G Seidel; Diane Nugent; Marc Michel; Thomas Kühne
Journal:  Blood Adv       Date:  2021-03-23

4.  Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases.

Authors:  Hamilton C Tsang; James B Bussel; Susan Mathew; Yen-Chun Liu; Allison A Imahiyerobo; Attilio Orazi; Julia T Geyer
Journal:  Mod Pathol       Date:  2017-01-06       Impact factor: 7.842

Review 5.  Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment.

Authors:  Markus G Seidel
Journal:  Blood       Date:  2014-08-27       Impact factor: 22.113

Review 6.  Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.

Authors:  Alessandro Pecci
Journal:  Int J Hematol       Date:  2013-05-01       Impact factor: 2.490

7.  Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia.

Authors:  Majed J Dasouki; Syed K Rafi; Adam J Olm-Shipman; Nathan R Wilson; Sunil Abhyankar; Brigitte Ganter; L Mike Furness; Jianwen Fang; Rodrigo T Calado; Irfan Saadi
Journal:  Blood       Date:  2013-10-01       Impact factor: 22.113

8.  Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects.

Authors:  Ben Johnson; Gillian C Lowe; Jane Futterer; Marie Lordkipanidzé; David MacDonald; Michael A Simpson; Isabel Sanchez-Guiú; Sian Drake; Danai Bem; Vincenzo Leo; Sarah J Fletcher; Ban Dawood; José Rivera; David Allsup; Tina Biss; Paula Hb Bolton-Maggs; Peter Collins; Nicola Curry; Charlotte Grimley; Beki James; Mike Makris; Jayashree Motwani; Sue Pavord; Katherine Talks; Jecko Thachil; Jonathan Wilde; Mike Williams; Paul Harrison; Paul Gissen; Stuart Mundell; Andrew Mumford; Martina E Daly; Steve P Watson; Neil V Morgan
Journal:  Haematologica       Date:  2016-06-16       Impact factor: 9.941

9.  ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization.

Authors:  Roberta Bottega; Caterina Marconi; Michela Faleschini; Gabriele Baj; Claudia Cagioni; Alessandro Pecci; Tommaso Pippucci; Ugo Ramenghi; Simonetta Pardini; Loretta Ngu; Carlo Baronci; Shinji Kunishima; Carlo L Balduini; Marco Seri; Anna Savoia; Patrizia Noris
Journal:  Blood       Date:  2014-10-31       Impact factor: 22.113

10.  Genome-wide linkage analysis and whole-exome sequencing identifies an ITGA2B mutation in a family with thrombocytopenia.

Authors:  Rami Khoriaty; Ayse B Ozel; Shweta Ramdas; Charles Ross; Karl Desch; Jordan A Shavit; Lesley Everett; David Siemieniak; Jun Z Li; David Ginsburg
Journal:  Br J Haematol       Date:  2019-05-23       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.